Fig. 4From: Deprescribing preventive cardiovascular medication in patients with predicted low cardiovascular disease risk in general practice – the ECSTATIC study: a cluster randomised non-inferiority trialIntention-to-treat and per-protocol analysis of the difference in mean increase in predicted 10-year CVD risk. The error bars depict the 95% CI of the estimated difference in increase of 10-year CVD risk between the usual care and intervention group 2 years after the first visit. aThe PP analysis includes only the 319 participants in the intervention group who had (temporarily) deprescibed their preventive cardiovascular medication. CVD cardiovascular disease, CI confidence interval, ITT intention-to-treat, PP per-protocolBack to article page